BUSINESS● LOWJun 24 · Jun 24, 2026, 5:33 AM
MoonLake Immunotherapeutics prices $200M public offering of Class A shares
Seeking Alpha Tech
MoonLake Immunotherapeutics has priced a $200 million public offering of its Class A shares.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS46m agoMoody's holds France's credit rating steady despite budget and political uncertaintyLe Monde [en]BUSINESS58m agoCan A Bigger Superior Refinery Lower Gas Prices ? Economists Say Nourbanmilwaukee.com · United States